Dhingra Ankur
- SEC CIK
- 0001849682
No open-market purchases or sales filed in the past year.
Current role at each company
- ILMN Illumina, Inc.SVP, Chief Financial Officeras of Mar 9, 2026
- SMMT Summit Therapeutics Inc.Chief Financial Officeras of Mar 27, 2024
- CDNA CareDx, Inc.Chief Financial Officeras of Mar 28, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dhingra Ankur as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ILMN Illumina, Inc.
SVP, Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 (view filing) | May 12 | 2 days | Dhingra AnkurSVP, Chief Financial Officer | PPurchase | +6.10K | $81.21 | +$495.4K | +32.4%24.9K after |
SMMT Summit Therapeutics Inc.
Chief Financial Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 (view filing) | Mar 26 | 1 day | Dhingra AnkurChief Financial Officer | PPurchase | +100.0K | $3.75 | +$375.0K | +39.2%355.0K after | |
| Dec 13, 2023 (view filing) | Dec 13 | Same day | Dhingra AnkurChief Financial Officer | PPurchase | +20.4K | $2.17 | +$44.3K | +8.7%255.0K after | 2 lots |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Dhingra AnkurChief Financial Officer | PPurchase | +196.4K | $1.05 | +$206.2K | +514.1%234.6K after | |
| Mar 8, 2023 (view filing) | Aug 16, 2022 | 204 days | Dhingra AnkurChief Financial Officer | PPurchase | +13.0K | $0.97 | +$12.6K | +49.2%39.5K after | Amended |
| Mar 8, 2023 (view filing) | Aug 16, 2022 | 204 days | Dhingra AnkurChief Financial Officer | PPurchase | +24.7K | $0.97 | +$23.9K | +182.1%38.2K after | Amended |
CDNA CareDx, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Dhingra AnkurChief Financial Officer | PPurchase | +5.00K | $42.34 | +$211.7K | New position5.00K after |